Afya Limited (NASDAQ:AFYA – Get Free Report) VP Lelio De Souza Junior sold 41,541 shares of the business’s stock in a transaction on Friday, June 26th. The stock was sold at an average price of $15.00, for a total value of $623,115.00. Following the completion of the transaction, the vice president directly owned 36,204 shares in the company, valued at approximately $543,060. This represents a 53.43% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink.
Lelio De Souza Junior also recently made the following trade(s):
- On Thursday, April 9th, Lelio De Souza Junior sold 16,279 shares of Afya stock. The shares were sold at an average price of $14.53, for a total value of $236,533.87.
- On Tuesday, April 7th, Lelio De Souza Junior sold 26,753 shares of Afya stock. The shares were sold at an average price of $14.95, for a total value of $399,957.35.
Afya Stock Performance
Afya stock opened at $14.84 on Wednesday. The stock has a 50-day simple moving average of $14.31 and a 200 day simple moving average of $14.53. The stock has a market capitalization of $1.39 billion, a price-to-earnings ratio of 9.70, a P/E/G ratio of 1.53 and a beta of 0.34. The company has a quick ratio of 1.78, a current ratio of 1.78 and a debt-to-equity ratio of 0.42. Afya Limited has a 12-month low of $13.00 and a 12-month high of $18.16.
Hedge Funds Weigh In On Afya
Wall Street Analysts Forecast Growth
A number of equities analysts have recently issued reports on AFYA shares. Zacks Research lowered shares of Afya from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, May 6th. Wall Street Zen cut shares of Afya from a “strong-buy” rating to a “buy” rating in a research report on Saturday, May 2nd. Bank of America reaffirmed a “neutral” rating on shares of Afya in a report on Thursday, June 11th. Weiss Ratings reiterated a “hold (c)” rating on shares of Afya in a research report on Monday, April 20th. Finally, JPMorgan Chase & Co. lowered their target price on Afya from $21.50 to $21.00 and set a “neutral” rating for the company in a research note on Monday, June 22nd. One equities research analyst has rated the stock with a Buy rating and seven have given a Hold rating to the company’s stock. According to MarketBeat, Afya currently has an average rating of “Hold” and an average price target of $17.10.
View Our Latest Report on AFYA
About Afya
Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.
At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.
See Also
- Five stocks we like better than Afya
- NextEra’s Dominion Deal Could Put It at the Center of the AI Power Race
- Amazon Could Be About to Reap the Rewards of a Software Spending Boom
- Best Buy’s Turnaround Is Gaining Traction, But Wall Street Still Needs Proof
- AI Fears Hit Nebius Stock, But Has the Growth Thesis Changed?
Receive News & Ratings for Afya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Afya and related companies with MarketBeat.com's FREE daily email newsletter.
